MT1 MMP inhibitors (State University of New York at Stony Brook)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMT1 MMP inhibitors (State University of New York at Stony Brook)

Drug Alias NameMMP-14 inhibitors (State University of New York at Stony Brook)matrix metalloproteinase-14 inhibitors (State University of New York at Stony Brook)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionMatrix metalloproteinase 14 inhibitors

TargetsMatrix metalloproteinase 14

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesState University of New York at Stony Brook

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesState University of New York at Stony Brook

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A